Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Oligomenorrhea × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 350 Neoplasms 315 Prostatic Neoplasms 182 Lung Neoplasms 149 Colorectal Neoplasms 119 Motor Activity 76 Uterine Cervical Neoplasms 69 Head and Neck Neoplasms 63 Carcinoma, Non-Small-Cell Lung 61 Brain Neoplasms 54 Ovarian Neoplasms 51 Pancreatic Neoplasms 44 Colonic Neoplasms 43 Precursor Cell Lymphoblastic Leukemia-Lymphoma 41 Anxiety Disorders 39 Neoplasm Metastasis 38 Multiple Myeloma 36 Melanoma 35 Rectal Neoplasms 34 Carcinoma, Hepatocellular 34 Urinary Bladder Neoplasms 32 Lymphoma 32 Hematologic Neoplasms 31 Pain 30 Depression 29 Sarcoma 28 Leukemia, Myeloid, Acute 28 Glioma 28 Endometrial Neoplasms 28 Stomach Neoplasms 27

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06800170 2026-01-06

HP-phD_Adolesc

Lo.Li.Pharma s.r.l

Phase NA Recruiting

Amenorrhea, Oligomenorrhea, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡